Market Movers (8-K)
See all →NASDAQ
Iveda Solutions, Inc. received a notice from Nasdaq regarding its failure to maintain the minimum $1 bid price requirement, initiating a 180-day compliance period.
Worse than expected
NASDAQ
Iveda Solutions, Inc. announced the successful re-election of its directors and the ratification of its independent accounting firm at its 2024 Annual Meeting of Stockholders.
NASDAQ
Iveda Solutions, Inc. announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement, resolving a previous delisting notice.
Better than expected
NASDAQ
Iveda Solutions, Inc. stockholders approved the issuance of Series A and Series B Common Stock Purchase Warrants at its reconvened 2024 Annual Meeting.
Capital raise
NASDAQ
Iveda Solutions, Inc. has been granted an extension until November 24, 2025, to regain compliance with Nasdaq's minimum stockholders' equity requirement, following a previous delisting notice.
Delay expected
Worse than expected
NASDAQ
8-K: Iveda Solutions Fails to Secure Shareholder Approval for Warrant Issuance, Adjourns Annual Meeting
Iveda Solutions, Inc. announced that its shareholders did not approve a key proposal for warrant issuance, leading to the adjournment of its 2024 Annual Meeting until August 29, 2025.
Delay expected
Worse than expected
Capital raise
Quarterly Earnings (10-Q)
See all →NASDAQ
Iveda Solutions reported a significant reduction in net loss for the nine months ended September 30, 2025, driven by increased revenue and decreased operating expenses, while also completing substantial capital raises.
Delay expected
Better than expected
Capital raise
NASDAQ
Iveda Solutions reported a significant 60% revenue increase and a 28% reduction in net loss for the first half of 2025, despite ongoing concerns about its ability to continue as a going concern.
Better than expected
Capital raise
NASDAQ
Iveda Solutions saw a significant increase in revenue for the three months ended March 31, 2025, primarily driven by equipment sales in Taiwan, but acknowledges ongoing concerns about its ability to continue as a going concern.
Capital raise
Better than expected
NASDAQ
Iveda Solutions saw a significant increase in revenue during the third quarter of 2024, driven by equipment sales, although the company still reported a net loss.
Worse than expected
Capital raise
NASDAQ
Iveda Solutions experienced a decrease in revenue but an increase in gross margin during the second quarter of 2024 compared to the same period in 2023.
Worse than expected
Capital raise
NASDAQ
10-Q: Iveda Solutions Reports First Quarter 2024 Results with Revenue Decline and Increased Operating Loss
Iveda Solutions experienced a significant decrease in revenue and an increase in operating losses for the first quarter of 2024 compared to the same period in 2023.
Worse than expected
Capital raise
Annual Reports (10-K)
NASDAQ
Iveda Solutions, Inc. has filed an amended annual report (10-K/A) to reflect restatements of prior financial periods, reporting continued net losses and a 'going concern' opinion, despite strategic focus on smart city technologies.
Worse than expected
Delay expected
Capital raise
NASDAQ
Iveda Solutions reports a slight decrease in revenue for 2024, accompanied by an increased net loss, as the company navigates a strategic shift towards AI and IoT technologies.
Capital raise
Worse than expected
Delay expected
NASDAQ
Iveda Solutions Inc. reports a 45% increase in revenue for the year ended December 31, 2023, driven by increased equipment sales.
Worse than expected
Capital raise
Insider Trading (Form 4)
See all →NASDAQ
Iveda Solutions, Inc. Director Robert Gillen's stock options were repriced to an exercise price of $0.29 per share, effective February 23, 2026.
Worse than expected
NASDAQ
Iveda Solutions' Chief Financial Officer, Robert J. Brilon, had 125,000 of his stock options repriced to an exercise price of $0.29 per share by the Board of Directors.
Worse than expected
NASDAQ
Iveda Solutions' director Alejandro Franco saw 25,000 of his stock options repriced to a lower exercise price of $0.29 per share.
Worse than expected
NASDAQ
Iveda Solutions' CEO, David H. Ly, had 175,000 stock options repriced by the Board of Directors to an exercise price of $0.29 per share.
Worse than expected
NASDAQ
Iveda Solutions' Director Joseph A. Farnsworth had 100,000 stock options repriced from $0.82 to $0.29 per share by the Board of Directors.
Worse than expected
NASDAQ
Iveda Solutions CEO David H. Ly has filed a Form 4 indicating a planned acquisition of 175,000 stock options with an exercise price of $0.82, scheduled to vest immediately on December 29, 2025.
Proxy Statements (Def-14A)
NASDAQ
Iveda Solutions, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 5, 2025, to elect four directors and ratify Weinberg & Company as its independent auditor.
NASDAQ
Iveda Solutions has adjourned its annual meeting for a second time, specifically regarding Proposal 5, to allow stockholders more time to vote on the issuance of warrants and related common stock.
Delay expected
Capital raise
NASDAQ
Iveda Solutions is holding its annual meeting to vote on key proposals including redomiciling to Delaware, electing directors, increasing authorized shares, and approving the issuance of warrants.
Capital raise
New Public Companies (S-1)
NASDAQ
Iveda Solutions, a smart city technology provider, filed an S-1/A registration statement to offer up to 5.4 million shares and warrants to raise capital, while auditors express substantial doubt about its ability to continue as a going concern.
Delay expected
Capital raise
Worse than expected
NASDAQ
Iveda Solutions, a smart city technology provider, filed an S-1 registration statement to offer common stock and warrants to raise capital for general corporate purposes, despite ongoing net losses and a going concern opinion.
Delay expected
Capital raise
Worse than expected
Schedule 13G - Passive Investments
See all →NASDAQ
Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have filed a Schedule 13G detailing their beneficial ownership of Iveda Solutions, Inc. common stock, limited by warrant conversion restrictions.
NASDAQ
Iroquois Capital Management LLC, along with Richard Abbe and Kimberly Page, has filed a Schedule 13G detailing their beneficial ownership of Iveda Solutions' common stock, primarily through warrants subject to ownership blockers.
NASDAQ
Lind Global Fund III LP, along with its affiliates, has disclosed a 9.99% beneficial ownership stake in Iveda Solutions, Inc., primarily through common stock and warrants.
NASDAQ
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 4.99% beneficial ownership stake in Iveda Solutions, Inc. common stock.
Capital raise
NASDAQ
Iroquois Capital Management, LLC and its principals, Richard Abbe and Kimberly Page, have disclosed beneficial ownership in Iveda Solutions, Inc., with Abbe holding a 6.4% stake.
Capital raise
NASDAQ
SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 4.99% Passive Stake in IVEDA SOLUTIONS, INC.
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.99% in IVEDA SOLUTIONS, INC.'s common stock.